716 NL-201 induces inflammation in a 'cold' tumor microenvironment through upregulation of MHC-I, expansion of the TCR repertoire, and potent antitumor activity when combined with PD-1 inhibition

• Ryan Swanson,
• Carl Walkey,
• Christie Mortales,
• Benjamin Dutzar,
• Jerry Chen,
• Alex Chen,
• Justin Huard,
• Luis Blancas-Mejia

Affiliations

Ryan Swanson

Aff688 Alpine Immune Sciences Seattle WA USA

Carl Walkey

2Neoleukin Therapeutics Inc, Seattle, WA, USA

Christie Mortales

Neoleukin Therapeutics, Inc., Seattle, WA, United States

Benjamin Dutzar

Neoleukin Therapeutics, Inc., Seattle, WA, United States

Jerry Chen

Neoleukin Therapeutics, Inc., Seattle, WA, United States

Alex Chen

Neoleukin Therapeutics, Inc., Seattle, WA, United States

Justin Huard

Neoleukin Therapeutics, Inc., Seattle, WA, United States

Luis Blancas-Mejia

Neoleukin Therapeutics, Inc., Seattle, WA, United States